The immune microenvironment of HPV-negative oral squamous cell carcinoma from never-smokers and never-drinkers patients suggests higher clinical benefit of IDO1 and PD1/PD-L1 blockade

Auteurs

J.-P. Foy, C. Bertolus, M.-C. Michallet, S. Deneuve, R. Incitti, N. Bendriss-Vermare, M.-A. Albaret, S. Ortiz-Cuaran, E. Thomas, A. Colombe, C. Py, N. Gadot, J.-P. Michot, J. Fayette, A. Viari, B. Van den Eynde, P. Goudot, M. Devouassoux-Shisheboran, A. Puisieux, C. Caux, P. Zrounba, S. Lantuejoul, P. Saintigny